Search results
Jun 24, 2024 · On 8th June 2024, Arthritis Foundation Malaysia hosted a remarkably successful patient education talk with the support from Sandoz Malaysia, focusing on the use of biologics and biosimilars in treating rheumatic and arthritic disorders.
5 days ago · Sandoz interview details: 191 interview questions and 182 interview reviews posted anonymously by Sandoz interview candidates.
6 days ago · Basel, July 1, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) has approved biosimilar Pyzchiva ...
Jun 28, 2024 · Step 1: Pre-submission of Application (Preparation) Step 2: Submission. Step 3: Screening. Step 4: Evaluation of Application. Step 5: Regulatory Outcome. Step 6: Post-Registration Process. National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. Malaysia Drug Control Authority.
Jun 10, 2024 · Under consideration since 2021, the details of the demerger of Sandoz, the generic drug arm of Swiss pharmaceutical giant Novartis, are becoming clearer. It will not be sold, but listed on the Swiss and US stock exchanges in the second half of 2023. Sandoz will be the number one listed generic player in Europe.
2 days ago · Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
2 days ago · Any inquiries regarding the Malaysia Digital Arrival Card (MDAC) application can be directed to: - http://eapp.imi.gov.my/spo
